Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000594908 | SCV000705654 | uncertain significance | not provided | 2017-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002315892 | SCV000739441 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2020-10-12 | criteria provided, single submitter | clinical testing | The p.L1805P variant (also known as c.5414T>C), located in coding exon 29 of the NOTCH1 gene, results from a T to C substitution at nucleotide position 5414. The leucine at codon 1805 is replaced by proline, an amino acid with similar properties. This alteration was reported in a bicuspid aortic valve cohort (Girdauskas E et al. Eur J Cardiothorac Surg, 2017 Jul;52:156-162). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV000655262 | SCV000777192 | benign | Adams-Oliver syndrome 5 | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000655262 | SCV002553353 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270717 | SCV002553354 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004530694 | SCV004119897 | uncertain significance | NOTCH1-related disorder | 2023-06-22 | criteria provided, single submitter | clinical testing | The NOTCH1 c.5414T>C variant is predicted to result in the amino acid substitution p.Leu1805Pro. This variant was reported in a study of individuals with bicuspid aortic valve-associated aortopathy, however additional details were not provided (Girdauskas et al. 2017. PubMed ID: 28387797; Girdauskas et al. 2018. PubMed ID: 30059548). This variant is reported in 0.011% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/9-139396511-A-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
ARUP Laboratories, |
RCV000594908 | SCV004564189 | uncertain significance | not provided | 2023-05-09 | criteria provided, single submitter | clinical testing | The NOTCH1 c.5414T>C; p.Leu1805Pro variant (rs201779159) is reported in the literature in an individual affected with bicuspid aortic valve disease (Girdauskas 2017). This variant is reported in ClinVar (Variation ID: 499922) and if found in the non-Finnish European population with an allele frequency of 0.0109% (14/128,060 alleles) in the Genome Aggregation Database. Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.648). Due to limited information, the clinical significance of this variant is uncertain at this time. References: Girdauskas E et al. Genetic abnormalities in bicuspid aortic valve root phenotype: preliminary results. Eur J Cardiothorac Surg. 2017 Jul 1;52(1):156-162. PMID: 28387797. |
John Welsh Cardiovascular Diagnostic Laboratory, |
RCV002285163 | SCV002575044 | uncertain significance | Pulmonary arterial hypertension | 2022-09-26 | no assertion criteria provided | clinical testing |